New patent for Nalpropion drug CONTRAVE

   November 2, 2021    Comments Off on New patent for Nalpropion drug CONTRAVE    Posted in: Patent Added

Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are fourteen patents protecting…

The post New patent for Nalpropion drug CONTRAVE appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog